Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Income Statement 2016–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenue | 673.0M | 560.0M | 434.0M | 363.3M | 351.4M | 271.0M | 103.7M | 51.5M | 2.6M | 133,000 |
| Gross Profit | — | — | — | — | — | — | — | 50.3M | 2.6M | — |
| Profitability | ||||||||||
| Operating Income | -535.0M | -536.0M | -569.0M | -648.9M | -381.7M | -330.1M | -424.2M | -371.4M | -328.9M | -248.0M |
| EBITDA | -500.0M | -500.0M | -543.0M | -630.7M | -368.5M | -317.9M | -415.6M | -351.8M | -323.1M | -244.6M |
| Net Income | -575.0M | -569.0M | -607.0M | -707.4M | -454.0M | -186.6M | -402.7M | -197.6M | -302.1M | -245.9M |
| Per Share Data | ||||||||||
| EPS (diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | — | — | — | — |
| Shares Outstanding (dil.) | 99M | 91M | 74M | 70M | 68M | 61M | 58M | 51M | 44M | 41M |
Ultragenyx Pharmaceutical Inc. Income Statement — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's income statement history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s income statement by year and by quarter, including the growth rate.